Please use this identifier to cite or link to this item:
Title: Hancornia speciosa Gomes (Apocynaceae) as a potential anti-diabetic drug
Keywords: Hancornia speciosa
Glucose uptake
Issue Date: 2015
Publisher: Elsevier Sequoia
Citation: PEREIRA, A. C. et al. Hancornia speciosa Gomes (Apocynaceae) as a potential anti-diabetic drug. Journal of Ethnopharmacology, Lausanne, v. 161, n. 23, p. 30–35, Feb. 2015.
Abstract: Ethnopharmacological relevance The leaves of Hancornia speciosa Gomes are traditionally used to treat diabetes in Brazil. The aim of the study is to evaluate the potential anti-diabetic effect of Hancornia speciosa extract and derived fractions. Materials and Methods The ethanolic extract from Hancornia speciosa leaves and chromatographic fractions thereof were evaluated on α-glucosidase assay, on hyperglycemic effect and glucose uptake. The chemical composition of the extract and its most active fraction was investigated by ESI–LC–MS. Results The ethanolic extract and derived fractions inhibited α-glucosidase in vitro. However, only the crude extract and the dichloromethane fraction inhibited the hyperglycemic effect induced by starch or glucose. Both the extract and dichloromethane fraction were also able to increase glucose uptake in adipocytes. Bornesitol, quinic acid, and chorogenic acid were identified in the extract, along with flavonoid glycosides, whereas the dichloromethane fraction is majorly composed by esters of lupeol and/or α/β-amirin. Conclusions Hancornia speciosa has a potential anti-diabetic effect through a mechanism dependent on inhibition of α-glucosidase and increase on glucose uptake. These results give support to the use on traditional medicine of this medicinal plant.
Appears in Collections:DME - Artigos publicados em periódicos

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.